Overview

Open-label Berotralstat Access to HAE Patients Previously Enrolled in Berotralstat Studies

Status:
Not yet recruiting
Trial end date:
2026-08-01
Target enrollment:
Participant gender:
Summary
This is a phase 3b open-label study providing access to berotralstat for HAE patients who were previously enrolled in berotralstat studies.
Phase:
Phase 3
Details
Lead Sponsor:
BioCryst Pharmaceuticals
Treatments:
Berotralstat